10/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

10/2023

Oct 15, 2023, 13:12 | Insight
Nalee Kim: We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes..
Nalee Kim, Radiation oncologist at Yonsei Cancer Center, shared on X/Twitter: "We recently found out…
Oct 14, 2023, 22:16 | Blog
Paolo Tarantino: So much going on in the ADC field.
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared the following on Twitter: "So…
Oct 14, 2023, 22:07 | Blog
Johanna Joyce: Excited for Drs. Ángel Álvarez-Prado and Spencer Watson, two wonderful postdocs in my lab, who are now on the job market.
Johanna Joyce, Professor at University of Lausanne - UNIL, made the following post on LinkedIn:…
Oct 14, 2023, 21:59 | Blog
The U-Link Canada team is at SIOP2023 in Ottawa! - U-Link Canada
U-Link Canada, made the following post on LinkedIn: "The U-Link Canada team is at SIOP2023…
Oct 14, 2023, 21:53 | Opinion
Biljana Naumovic: Building equitable access should be an all-encompassing priority – not an afterthought or a last step.
Biljana Naumovic, Worldwide Vice President Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson…
Oct 14, 2023, 21:44 | Blog
This unique alliance with Takeda aims to accelerate the development of novel treatments to bring groundbreaking cancer research discoveries to patients. - The Mark Foundation for Cancer Research
Oct 14, 2023, 21:38 | Blog
Maite Gorostegui: The SIOP Global Mapping Programme is now a reality...from "Tijuana to Tierra del Fuego" in Latin America (more than 200 centeres) and more than 100.
Maite Gorostegui, Pediatric Oncologist at Pediatric Cancer Center Barcelona, shared a post by Jennifer Geel,…
Oct 14, 2023, 18:26 | Blog
The House approves $25M for NF; onward to the Senate! - Children's Tumor Foundation
Rebecca Brown, Assistant Professor at The Mount Sinai Hospital, shared a post by Children's Tumor…
Oct 14, 2023, 18:26 | Blog
VIGex: a VHIO-developed predictive, pan-cancer platform to help guide patient selection for personalized immunotherapy. - Vall d'Hebron Institute of Oncology
Quoting Vall d'Hebron Institute of Oncology on LinkedIn: "VIGex: a VHIO-developed predictive, pan-cancer platform to…
Oct 14, 2023, 18:25 | Blog
Paul Pearlman: In case you missed them, here are the funding solicitations announced at the Grand Challenges meeting this week.
Paul Pearlman, Program Director/Lead for Global Health Technology at NCI, recently shared on LinkedIn: "In…
All: 805 Posts: 431 - 440